Cancer Consult: Expertise in Clinical Practice, Volume 1

Syed A. Abutalib, MD, is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP® Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), Part of City of Hope. Maurie Markman, MD, is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope. Al B. Benson III, M.D FACP FASCO, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois, and the Associate Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center. Hope S. Rugo, MD, FASCO, is Director of Breast Oncology and Clinical Trials Education and a Professor of Medicine at the University of California San Francisco Comprehensive Cancer Center.

• Editors Volume 1 xiVolume 2: Neoplastic Hematology & Cellular TherapyEditors xiiEditor's Biography xiiiPreface xvAcknowledgment xviiPart 1 Central Nervous System 11 Central Nervous System Tumors 3Mark R. Gilbert and Edina Komlodi-PasztorPart 2 Head and Neck and Thoracic Cancers 132 Localized Head and Neck Cancer 15Emrullah Yilmaz and Jessica L. Geiger3 Recurrent and Metastatic Head and Neck Cancer 31Chloe Weidenbaum and Mike Gibson4 Thyroid Cancers 39Kartik Sehgal and Jochen H. Lorch5 Non-Small Cell Lung Cancer: Screening, Staging, and Stage I 51Ryan D. Gentzler and Linda W. Martin6 Non-Small Cell Lung Cancer: Stages II and III 63Gregory Peter Kalemkerian, Kamya Sankar, and Angel Qin7 Recurrent and Metastatic Non-Small Cell Lung Cancer 79Julia Judd, J. Nicholas Bodor, and Hossein Borghaei8 Small Cell Lung Cancer 97Jyoti D. Patel and Husam Hafzah9 Mesothelioma 105Harvey I. Pass, David Chen, and Jack DonaghuePart 3 Breast Cancer 11510 DCIS and LCIS 117Amanda Nash, Rita Mukhtar, and Shelley Hwang11 Early-Stage ER/PR –Positive, HER2-Negative Breast Cancer 129William J. Gradishar12 ER/PR-Positive, HER2-Negative Metastatic Breast Cancer 139Sara Nunnery, Laura Kennedy, and Sonya Reid13 Early-Stage HER2-Positive Breast Cancer 151Erin Roesch and Jame Abraham14 HER2-Positive Metastatic Breast Cancer 163Reshma L. Mahtani, Naomi G. Dempsey, and Ana Sandoval15 Early-Stage Triple-Negative Breast Cancer 179Tiffany A. Traina, Carlos dos Anjos, and Elaine Walsh16 Triple-Negative Metastatic Breast Cancer 191Azadeh Nasrazadani, Juan Gomez, and Adam Brufsky17 Inflammatory Breast Cancer – A Distinct Entity 201Massimo Cristofanilli and Elena Vagia18 Male Breast Cancer 213Laura A. Huppert, Ozge Gumusay, Shreya Desai, and Hope S. Rugo19 Breast Cancer in Pregnancy and Fertility Preservation 225Fedro A. Peccatori, Hatem Azim, and Matteo LambertiniPart 4 Gastrointestinal Cancers 23320 Early-Stage Gastroesophageal Cancer and Precursor Lesions 235Yixing Jiang and Aaron Ciner21 Metastatic Esophagogastric Cancer 249Geoffrey Y. Ku and David H. Ilson22 Early-Stage Colon Cancer 255John Krauss, Vaibhav Sahai, and Al B. Benson III23 Early-Stage Rectal Cancer 267Hannah J. Roberts, Theodore Hong, and Aparna Parikh24 Recurrent and Metastatic Colorectal Cancer 283Joseph Heng and Blase Polite25 Pancreatic Adenocarcinoma 291Evan Walker, Andrew Ko, and Margaret Tempero26 Hepatocellular Cancer 309Pedro Luiz Serrano Uson Junior and Mitesh Borad27 Biliary Tract Cancers 319David B. Zhen and Vaibhav Sahai28 Carcinoid and Neuroendocrine Tumors 327Mintallah Haider and Jonathan Strosberg 29 Anal Cancer 343Asad Mahmood and Rob Glynne-JonesPart 5 Genitourinary Cancers 35930 Renal Cancer 361James L. Coggan, Alan Tan, and Timothy M. Kuzel31 Bladder Cancer 375Revathi Kollipara, Alan Tan, and Timothy M. Kuzel32 Prostate Cancer: Screening, Surveillance, Prognostic Algorithms, and Independent Pathologic Predictive Parameters 389Eduardo Benzi and Thomas M. Wheeler33 Early and Locally Advanced Prostate Cancer 399James Randall, Mohammad R. Siddiqui, Ashley Ross, and Sean Sachdev34 Metastatic Prostate Cancer 421Priyanka Chablani, Natalie Reizine, and Walter Stadler35 Germ Cell Tumors 437Hamid Emamekhoo, Syed A. Abutalib, and Timothy GilliganPart 6 Skin Malignancies 45336 Melanoma 455Ana M. Ciurea and Kim Margolin37 Nonmelanoma Skin Cancers 477Chrysalyne D. Schmults and Danielle A. ParkerPart 7 Gynecological Cancers 49738 Ovarian Cancer: Primary Treatment and Approach to Recurrent Disease 499Rani Bansal, Don Dizon, and Martina Murphy39 Ovarian Cancer: Second-line Treatment Strategies 511Maurie Markman40 Endometrial Cancer 523Maurie Markman41 Cancer of the Cervix, Vulva, and Vagina 533Sabrina M. Bedell and Peter G. Rose42 Uncommon Gynecologic Cancers 549Michael Frumovitz, Shannon Westin, and David M. GershensonPart 8 Sarcomas 56543 Bone Sarcomas 567Nicole Larrier, William Eward, and Richard F. Riedel44 Soft Tissue Sarcomas 579Jeffrey Farma, Krisha Howell, and Margaret von MehrenPart 9 Hereditary Cancer Syndromes and Genetic Testing 59545 Hereditary Cancer Syndromes 597Mary B. Daly46 Hereditary Breast and Ovarian Cancer Syndromes 611Kristen Whitaker and Elias Obeid47 Hereditary Gastrointestinal and Pancreatic Cancer Syndromes 625Kristen M. Shannon, Linda H. Rodgers-Fouche, and Daniel C. ChungPart 10 Special Issues in Oncology 63748 Cancer of Unknown Primary 639Tony Greco49 Anticoagulation in Cancer 651Jean Marie Connors50 Identification and Management of Immunotherapy-Related Adverse Events in Oncology 663Ozge Gumusay, Laura A. Huppert, Dame Idossa, and Hope S. Rugo51 Geriatric Oncology 677Sukeshi Patel Arora and Efrat Dotan52 Palliative Medicine for Curable and Terminal Cancers 693Isabelle Blanchard, Kavitha Jennifer Ramachandran, and Divya GuptaIndex 709